51 Live Notices for Rivaroxaban Tenders
Showing 1 to 20
Supply Of Medications For The Mining Hospital. Quote According To The Attached List, Annex I Which Is Part Of This Sheet
10 Mar 2025
12 Mar 20251 Buspirone 10 Mg 2 Comb. Drug (Ascorbic Acid, Ferrous Sulphate) (100 Mg +60 Mg) 3 Comb. Drug (Budesonide, Formeterol) 160/4.5 Μg 60 Doses 4 Comb. Drug (Trimethoprim, Sulfamethoxazole) 480 Mg 5 Fexofenadine 180 Mg 6 Levetiracetam 500 Mg 7 Levocetirizine 5 Mg 8 Levomepromazine 25 Mg 9 Methyldopa 250 Mg 10 Propranolol 10 Mg 11 Rivaroxaban 20 Mg
1 Buspirone 10 Mg 2 Comb. Drug (Ascorbic Acid, Ferrous Sulphate) (100 Mg +60 Mg) 3 Comb. Drug (Budesonide, Formeterol) 160/4.5 Μg 60 Doses 4 Comb. Drug (Trimethoprim, Sulfamethoxazole) 480 Mg 5 Fexofenadine 180 Mg 6 Levetiracetam 500 Mg 7 Levocetirizine 5 Mg 8 Levomepromazine 25 Mg 9 Methyldopa 250 Mg 10 Propranolol 10 Mg 11 Rivaroxaban 20 Mg
The Object Of Purchase Is The Medication Of Various Pharmaco-Therapeutic Groups
The Object Of Purchase Is The Medication Of Various Pharmaco-Therapeutic Groups
The Object Of Purchase Is The Medication Of Various Pharmaco-Therapeutic Groups
The Object Of Purchase Is The Medication Of Various Pharmaco-Therapeutic Groups
Supply Of Terlipresin And Rivaroxaban
Supply Of Terlipresin And Rivaroxaban
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Of The Social Code Book V With The Active Ingredient Rivaroxaban In The Dosage Form Hkp
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Of The Social Code Book V With The Active Ingredient Rivaroxaban In The Dosage Form Hkp
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Rivaroxaban (Atc Code According To Who: B01Af01)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Rivaroxaban (Atc Code According To Who: B01Af01)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Rivaroxaban (Atc Code According To Who: B01Af01)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Rivaroxaban (Atc Code According To Who: B01Af01)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Rivaroxaban (Atc Code According To Who: B01Af01)
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Rivaroxaban (Atc Code According To Who: B01Af01)
Mspas No. 2024-Roo-C196, Acquisition Of Rivaroxaban, For The Roosevelt Hospital
Mspas No. 2024-Roo-C196, Acquisition Of Rivaroxaban, For The Roosevelt Hospital
Medicines With The Active Ingredient Rivaroxaban (Atc: B01Af01 - With A Potency Of 2.5 Mg Per Divided Oral Dosage Form)
Tenders by Country